These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 10463475

  • 1. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
    Erdamar S, Yang G, Harper JW, Lu X, Kattan MW, Thompson TC, Wheeler TM.
    Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475
    [Abstract] [Full Text] [Related]

  • 2. Expression of p27kip1 in prostatic adenocarcinoma.
    Cheville JC, Lloyd RV, Sebo TJ, Cheng L, Erickson L, Bostwick DG, Lohse CM, Wollan P.
    Mod Pathol; 1998 Apr; 11(4):324-8. PubMed ID: 9578081
    [Abstract] [Full Text] [Related]

  • 3. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
    Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM.
    Cancer Res; 1998 Feb 01; 58(3):542-8. PubMed ID: 9458103
    [Abstract] [Full Text] [Related]

  • 4. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
    Fernández PL, Arce Y, Farré X, Martínez A, Nadal A, Rey MJ, Peiró N, Campo E, Cardesa A.
    J Pathol; 1999 Apr 01; 187(5):563-6. PubMed ID: 10398122
    [Abstract] [Full Text] [Related]

  • 5. Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
    Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, deKernion JB, Loda M, Reiter RE.
    J Urol; 1998 Mar 01; 159(3):941-5. PubMed ID: 9474188
    [Abstract] [Full Text] [Related]

  • 6. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
    Guo Y, Sklar GN, Borkowski A, Kyprianou N.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2269-74. PubMed ID: 9815624
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
    Vis AN, Noordzij MA, Fitoz K, Wildhagen MF, Schröder FH, van der Kwast TH.
    J Urol; 2000 Dec 01; 164(6):2156-61. PubMed ID: 11061947
    [Abstract] [Full Text] [Related]

  • 8. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.
    Revelos K, Petraki C, Gregorakis A, Scorilas A, Papanastasiou P, Tenta R, Koutsilieris M.
    In Vivo; 2005 Dec 01; 19(5):911-20. PubMed ID: 16097446
    [Abstract] [Full Text] [Related]

  • 9. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.
    J Urol; 1999 Apr 01; 161(4):1229-32. PubMed ID: 10081875
    [Abstract] [Full Text] [Related]

  • 10. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
    Kuczyk M, Machtens S, Hradil K, Schubach J, Christian W, Knüchel R, Hartmann J, Bokemeyer C, Jonas U, Serth J.
    Br J Cancer; 1999 Nov 01; 81(6):1052-8. PubMed ID: 10576664
    [Abstract] [Full Text] [Related]

  • 11. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage.
    Thomas GV, Schrage MI, Rosenfelt L, Kim JH, Salur G, deKernion JB, Dorey F, Said J, Reiter RE.
    J Urol; 2000 Dec 01; 164(6):1987-91. PubMed ID: 11061897
    [Abstract] [Full Text] [Related]

  • 12. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM, Meeker AK, Epstein JI, Coffey DS.
    Am J Pathol; 1998 Sep 01; 153(3):911-9. PubMed ID: 9736039
    [Abstract] [Full Text] [Related]

  • 13. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
    Zheng XY, Ding W, Xie LP, Chen ZD.
    Ai Zheng; 2004 Feb 01; 23(2):215-8. PubMed ID: 14960249
    [Abstract] [Full Text] [Related]

  • 14. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA, Quast BJ, Wilson MJ, Fernandes ET, Reddy PK, Ewing SL, Gleason DF.
    Cancer; 2002 Jun 15; 94(12):3141-9. PubMed ID: 12115346
    [Abstract] [Full Text] [Related]

  • 15. Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer.
    Ben-Izhak O, Lahav-Baratz S, Meretyk S, Ben-Eliezer S, Sabo E, Dirnfeld M, Cohen S, Ciechanover A.
    J Urol; 2003 Jul 15; 170(1):241-5. PubMed ID: 12796697
    [Abstract] [Full Text] [Related]

  • 16. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV.
    Mod Pathol; 1998 Feb 15; 11(2):169-74. PubMed ID: 9504687
    [Abstract] [Full Text] [Related]

  • 17. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A, International Breast Cancer Study Group.
    Cancer; 2003 Apr 01; 97(7):1591-600. PubMed ID: 12655514
    [Abstract] [Full Text] [Related]

  • 18. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.
    Hum Pathol; 2000 Jun 01; 31(6):751-60. PubMed ID: 10872671
    [Abstract] [Full Text] [Related]

  • 19. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.
    Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, Timme TL, Baba S, Thompson TC.
    Cancer; 2003 Mar 01; 97(5):1225-33. PubMed ID: 12599229
    [Abstract] [Full Text] [Related]

  • 20. Low p27 expression predicts biochemical relapse after radical prostatectomy in patients with clinically localised prostate cancer.
    Ribal MJ, Fernandez PL, Lopez-Guillermo A, Farré X, Santos Y, Gibanel R, Cardesa A, Alcaraz A.
    Anticancer Res; 2003 Mar 01; 23(6D):5101-6. PubMed ID: 14981973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.